![PDF) Parums DV. Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir. Med Sci Monit. 2022;28:e938532. PDF) Parums DV. Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir. Med Sci Monit. 2022;28:e938532.](https://i1.rgstatic.net/publication/364087739_Parums_DV_Editorial_Rebound_COVID-19_and_Cessation_of_Antiviral_Treatment_for_SARS-CoV-2_with_Paxlovid_and_Molnupiravir_Med_Sci_Monit_202228e938532/links/63387c4e769781354eaec697/largepreview.png)
PDF) Parums DV. Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir. Med Sci Monit. 2022;28:e938532.
![PDF) Parums DV. Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19. Med Sci Monit. 2022 May 1;28:e937048. | Dinah Parums - PDF) Parums DV. Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19. Med Sci Monit. 2022 May 1;28:e937048. | Dinah Parums -](https://0.academia-photos.com/attachment_thumbnails/85285906/mini_magick20220501-30076-we34dy.png?1651420263)
PDF) Parums DV. Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19. Med Sci Monit. 2022 May 1;28:e937048. | Dinah Parums -
![Representação gráfica do Índice de Incremento -AIx (adaptado de Med... | Download Scientific Diagram Representação gráfica do Índice de Incremento -AIx (adaptado de Med... | Download Scientific Diagram](https://www.researchgate.net/publication/276305761/figure/fig2/AS:391820904288256@1470428791238/Figura-2-Representacao-grafica-do-Indice-de-Incremento-AIx-adaptado-de-Med-Sci-Monit.png)
Representação gráfica do Índice de Incremento -AIx (adaptado de Med... | Download Scientific Diagram
![PDF) Retracted: Phenotype of Vascular Smooth Muscle Cells (VSMCs) Is Regulated by miR-29b by Targeting Sirtuin 1 PDF) Retracted: Phenotype of Vascular Smooth Muscle Cells (VSMCs) Is Regulated by miR-29b by Targeting Sirtuin 1](https://i1.rgstatic.net/publication/356997266_Retracted_Phenotype_of_Vascular_Smooth_Muscle_Cells_VSMCs_Is_Regulated_by_miR-29b_by_Targeting_Sirtuin_1/links/61d9b96dda5d105e55295818/largepreview.png)